These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Stem cell transplantation for autoimmune diseases. Gratwohl A; Passweg J; Gerber I; Tyndall A; Best Pract Res Clin Haematol; 2001 Dec; 14(4):755-76. PubMed ID: 11924920 [TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770 [TBL] [Abstract][Full Text] [Related]
10. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience. Fassas A; Kimiskidis VK J Neurol Sci; 2004 Aug; 223(1):53-8. PubMed ID: 15261561 [TBL] [Abstract][Full Text] [Related]
11. Adult stem cells in the treatment of autoimmune diseases. van Laar JM; Tyndall A Rheumatology (Oxford); 2006 Oct; 45(10):1187-93. PubMed ID: 16777856 [TBL] [Abstract][Full Text] [Related]
12. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. Capello E; Saccardi R; Murialdo A; Gualandi F; Pagliai F; Bacigalupo A; Marmont A; Uccelli A; Inglese M; Bruzzi P; Sormani MP; Cocco E; Meucci G; Massacesi L; Bertolotto A; Lugaresi A; Merelli E; Solari A; Filippi M; Mancardi GL; Neurol Sci; 2005 Dec; 26 Suppl 4():S200-3. PubMed ID: 16388358 [TBL] [Abstract][Full Text] [Related]
13. [Stem cell transplantation in primary systemic vasculitis]. Hensel M; Fiehn C; Ho AD Med Klin (Munich); 2003 Jan; 98(1):13-8. PubMed ID: 12540989 [TBL] [Abstract][Full Text] [Related]
14. Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of action. Van Wijmeersch B; Sprangers B; Dubois B; Waer M; Billiau AD J Neuroimmunol; 2008 Jul; 197(2):89-98. PubMed ID: 18541311 [TBL] [Abstract][Full Text] [Related]
15. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis. Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768 [TBL] [Abstract][Full Text] [Related]
16. Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Marmont AM Best Pract Res Clin Haematol; 2004 Jun; 17(2):223-32. PubMed ID: 15302336 [TBL] [Abstract][Full Text] [Related]
17. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
18. High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosis. van Laar JM; McSweeney PA Best Pract Res Clin Haematol; 2004 Jun; 17(2):233-45. PubMed ID: 15302337 [TBL] [Abstract][Full Text] [Related]
19. Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks. Capello E; Vuolo L; Gualandi F; Van Lint MT; Roccatagliata L; Bonzano L; Pardini M; Uccelli A; Mancardi G Neurol Sci; 2009 Oct; 30 Suppl 2():S175-7. PubMed ID: 19882370 [TBL] [Abstract][Full Text] [Related]